Newsday - April 15, 2003
Laurie Garrett, Staff Writer
The findings are remarkable because of their speed - by comparison, it took nearly three years to find the virus that causes AIDS and another two years to determine its full genetic sequence - and their almost letter-for-letter similarity. The CDC's genomic sequence is longer than the Canadians' by only 15 genetic letters, or nucleotides - a mere blip in the virus' total of 29,736 nucleotides. The makeup of a virus is expected to vary slightly by geographic region. But coupled with optimism that the finding can serve as a road map for developing diagnostic tests, drug development and a vaccine is the continuing mystery: The virus is completely different from any known animal or human pathogen, and public health authorities are unable to conjecture where or how it originated.
It has been presumed that the SARS virus mutated from one that infects animals. But both teams concluded that it bears no resemblance to any known human or animal virus, and actually constitutes its own subclass within the coronavirus family.
"We need to go to China [where the outbreak began] and really do the shoe-leather detective work to find out who were the first cases, where did they go, what did they do," and with what animals might they have been in contact, Dr. Julie Gerberding, director of the national Centers for Disease Control and Prevention said yesterday.
She characterized the decoding of the virus as "tremendously exciting," especially because it was accomplished in 31 days. "It's a scientific achievement that I don't think has ever been paralleled in human history."
The CDC's announcement came on the heels of the weekend's genetic sequencing announcement from the British Columbia Cancer Agency in Vancouver. Though researchers the world over are collaborating in efforts to control SARS - to date it has caused 3,169 cases, 144 of them fatal - there was a competitive breathlessness to the Canadian and CDC reports.
The determination of whether the virus actually causes SARS must await identification of an animal that can be infected with the virus. So far, researchers have not been able to infect and produce the disease in animals. Gerberding indicated yesterday that a lab in the Netherlands may soon have promising results in primates.
Labs in Hong Kong, Japan and Europe are working on their own genetic sequences of the virus, and those findings are expected to shed light on geographic differences, perhaps addressing the issue of "super-spreaders" - people who are so contagious that they seem to infect everybody with whom they come in contact. In Singapore, for example, 60 SARS cases are linked to two wards of Singapore General Hospital. Yesterday the Ministry of Health said the outbreak started with a 90-year-old Chinese woman who passed her infection on to her nursing home attendant. The elderly woman died; the attendant and two other family members are hospitalized. Nearly everyone on the two wards who came within a few feet of the elderly woman later developed the disease.
In Britain, authorities confirmed recently that a man who waited for his plane at Heathrow Airport in London apparently caught SARS from a stranger seated near him in the waiting area. The stranger had traveled from Hong Kong.
030415
ND030401
Copyright © 2003 - Newsday. All rights reserved. All pages of newsday.com are copyright © Newsday, Inc. Other parties may also own rights to portions of newsday.com content. No portion of newsday.com content may be published, broadcast or distributed, directly or indirectly, in any medium without Newsday's prior written consent. Newsday, Inc. will not be held liable for any delays, inaccuracies, errors or omissions in any content on newsday.com. http://www.newsday.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .